Monoclonal antibodies directed against human FcRn and their applications

References

• Ghetie V, Ward ES. Multiple roles for the major histocompatibility complex class I-related receptor FcRn. Annu Rev Immunol 2000; 18:739 - 766; PMID: 10837074; http://dx.doi.org/10.1146/annurev.immunol.18.1.739
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007; 7:715 - 725; PMID: 17703228; http://dx.doi.org/10.1038/nri2155
   PubMed Web of Science ®Google Scholar
• Ward ES, Ober RJ. Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn. Adv Immunol 2009; 103:77 - 115; PMID: 19755184; http://dx.doi.org/10.0016/S0065-2776(09)03004-1
   PubMed Web of Science ®Google Scholar
• Kuo TT, Baker K, Yoshida M, Qiao SW, Aveson VG, Lencer WI, et al. Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 2010; 30:777 - 789; PMID: 20886282; http://dx.doi.org/10.1007/s10875-010-9468-4
   PubMed Web of Science ®Google Scholar
• Andersen JT, Sandlie I. The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics. Drug Metab Pharmacokinet 2009; 24:318 - 332; PMID: 19745559; http://dx.doi.org/10.2133/dmpk.24.318
   PubMed Web of Science ®Google Scholar
• Tesar DB, Björkman PJ. An intracellular traffic jam: Fc receptor-mediated transport of immunoglobulin G. Curr Opin Struct Biol 2010; 20:226 - 233; PMID: 20171874; http://dx.doi.org/10.1016/j.sbi.2010.01.010
   PubMed Web of Science ®Google Scholar
• He W, Ladinsky MS, Huey-Tubman KE, Jensen GJ, McIntosh JR, Björkman PJ. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature 2008; 455:542 - 546; PMID: 18818657; http://dx.doi.org/10.1038/nature07255
   PubMed Web of Science ®Google Scholar
• Gan Z, Ram S, Vaccaro C, Ober RJ, Ward ES. Analyses of the recycling receptor, FcRn, in live cells reveal novel pathways for lysosomal delivery. Traffic 2009; 10:600 - 614; PMID: 19192244; http://dx.doi.org/10.1111/j.1600-0854.2009.00887.x
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Christianson GJ, Sproule TJ, Brown AC, Akilesh S, Jung N, et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis and fate of IgG-Fc-coupled drugs. J Immunol 2003; 170:3528 - 3533; PMID: 12646614
   PubMed Web of Science ®Google Scholar
• Baker K, Qiao SW, Kuo T, Kobayashi K, Yoshida M, Lencer WI, et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol 2009; 31:223 - 236; PMID: 19495758; http://dx.doi.org/10.1007/s00281-009-0160-9
   PubMed Web of Science ®Google Scholar
• Baker K, Qiao SW, Kuo TT, Aveson VG, Platzer B, Andersen JT, et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci USA 2011; 108:9927 - 9932; PMID: 21628593; http://dx.doi.org/10.1073/pnas.1019037108
   PubMed Web of Science ®Google Scholar
• Liu X, Lu L, Yang Z, Palaniyandi S, Zeng R, Gao LY, et al. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J Immunol 2011; 186:4674 - 4686; PMID: 21402891; http://dx.doi.org/10.4049/jimmunol.1003584
   PubMed Web of Science ®Google Scholar
• Ye L, Zeng R, Bai Y, Roopenian DC, Zhu X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat Biotechnol 2011; 29:158 - 163; PMID: 21240266; http://dx.doi.org/10.1038/nbt.1742
   PubMed Web of Science ®Google Scholar
• Lu L, Palaniyandi S, Zeng R, Bai Y, Liu X, Wang Y, et al. A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection. J Virol 2011; 85:10542 - 10553; PMID: 21849464; http://dx.doi.org/10.1128/JVI.05441-11
   PubMed Web of Science ®Google Scholar
• Andersen JT, Dee Qian J, Sandlie I. The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. Eur J Immunol 2006; 36:3044 - 3051; PMID: 17048273; http://dx.doi.org/10.1002/eji.200636556
   PubMed Web of Science ®Google Scholar
• Anderson CL, Chaudhury C, Kim J, Bronson CL, Wani MA, Mohanty S. Perspective—FcRn transports albumin: relevance to immunology and medicine. Trends Immunol 2006; 27:343 - 348; PMID: 16731041; http://dx.doi.org/10.1016/j.it.2006.05.004
   PubMed Web of Science ®Google Scholar
• Neumann E, Frei E, Funk D, Becker MD, Schrenk HH, Müller-Ladner U, et al. Native albumin for targeted drug delivery. Expert Opin Drug Deliv 2010; 7:915 - 925; PMID: 20586704; http://dx.doi.org/10.1517/17425247.2010.498474
   PubMed Web of Science ®Google Scholar
• Andersen JT, Pehrson R, Tolmachev V, Daba MB, Abrahmsén L, Ekblad C. Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain. J Biol Chem 2011; 286:5234 - 5241; PMID: 21138843; http://dx.doi.org/10.1074/jbc.M110.164848
   PubMed Web of Science ®Google Scholar
• Akilesh S, Huber TB, Wu H, Wang G, Hartleben B, Kopp JB, et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci USA 2008; 105:967 - 972; PMID: 18198272; http://dx.doi.org/10.1073/pnas.0711515105
   PubMed Web of Science ®Google Scholar
• Haymann JP, Levraud JP, Bouet S, Kappes V, Hagíge J, Nguyen G, et al. Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol 2000; 11:632 - 639; PMID: 10752522
   PubMed Web of Science ®Google Scholar
• Andersen JT, Dalhus B, Cameron J, Daba MB, Plumridge A, Evans L, et al. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nat Commun 2012; 3:610; PMID: 22215085; http://dx.doi.org/10.1038/ncomms1607
   PubMed Web of Science ®Google Scholar
• Burmeister WP, Huber AH, Bjorkman PJ. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 1994; 372:379 - 383; PMID: 7969498; http://dx.doi.org/10.1038/372379a0
   PubMed Web of Science ®Google Scholar
• Martin WL, West AP Jr, Gan L, Bjorkman PJ. Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol Cell 2001; 7:867 - 877; PMID: 11336709; http://dx.doi.org/10.1016/S1097-2765(01)00230-1
   PubMed Web of Science ®Google Scholar
• Christianson GJ, Blankenburg RL, Duffy TM, Panka D, Roths JB, Marshak-Rothstein A, et al. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J Immunol 1996; 156:4932 - 4939; PMID: 8648144
   PubMed Web of Science ®Google Scholar
• Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol 1996; 26:690 - 696; PMID: 8605939; http://dx.doi.org/10.1002/eji.1830260327
   PubMed Web of Science ®Google Scholar
• Israel EJ, Wilsker DF, Hayes KC, Schoenfeld D, Simister NE. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 1996; 89:573 - 578; PMID: 9014824; http://dx.doi.org/10.1046/j.1365-2567.1996.d01-775.x
   PubMed Web of Science ®Google Scholar
• Jin F, Balthasar JP. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura. Hum Immunol 2005; 66:403 - 410; PMID: 15866704; http://dx.doi.org/10.1016/j.humimm.2005.01.029
   PubMed Web of Science ®Google Scholar
• Akilesh S, Petkova S, Sproule TJ, Shaffer DJ, Christianson GJ, Roopenian D. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest 2004; 113:1328 - 1333; PMID: 15124024
   PubMed Web of Science ®Google Scholar
• Li N, Zhao M, Hilario-Vargas J, Prisayanh P, Warren S, Diaz LA, et al. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest 2005; 115:3440 - 3450; PMID: 16284651; http://dx.doi.org/10.1172/JCI24394
   PubMed Web of Science ®Google Scholar
• Vaccaro C, Zhou J, Ober RJ, Ward ES. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol 2005; 23:1283 - 1288; PMID: 16186811; http://dx.doi.org/10.1038/nbt1143
   PubMed Web of Science ®Google Scholar
• Petkova SB, Akilesh S, Sproule TJ, Christianson GJ, Al Khabbaz H, Brown AC, et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 2006; 18:1759 - 1769; PMID: 17077181; http://dx.doi.org/10.1093/intimm/dxl110
   PubMed Web of Science ®Google Scholar
• Patel DA, Puig-Canto A, Challa DK, Perez Montoyo H, Ober RJ, Ward ES. Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model. J Immunol 2011; 187:1015 - 1022; PMID: 21690327; http://dx.doi.org/10.4049/jimmunol.1003780
   PubMed Web of Science ®Google Scholar
• Mezo AR, Sridhar V, Badger J, Sakorafas P, Nienaber V. X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn. J Biol Chem 2010; 285:27694 - 27701; PMID: 20592032; http://dx.doi.org/10.1074/jbc.M110.120667
   PubMed Web of Science ®Google Scholar
• Liu L, Garcia AM, Santoro H, Zhang Y, McDonnell K, Dumont J, et al. Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade. J Immunol 2007; 178:5390 - 5398; PMID: 17404325
   PubMed Web of Science ®Google Scholar
• Ober RJ, Radu CG, Ghetie V, Ward ES. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol 2001; 13:1551 - 1559; PMID: 11717196; http://dx.doi.org/10.1093/intimm/13.12.1551
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Christianson GJ, Sproule TJ. Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies. Methods Mol Biol 2010; 602:93 - 104; PMID: 20012394; http://dx.doi.org/10.1007/978-1-60761-058-8_6
   PubMedGoogle Scholar